Exposure Draft and comment letters: Amendments to the Fair Value Option for Investments in Associates and Joint Ventures

In February 2026, the International Accounting Standards Board (IASB) published the Exposure Draft Amendments to the Fair Value Option for Investments in Associates and Joint Ventures. The Exposure Draft proposes narrow-scope amendments to clarify which entities are eligible to measure investments in associates and joint ventures using the fair value option in IAS 28 Investments in Associates and Joint Ventures.

The Exposure Draft responds to feedback from stakeholders that identified diversity in how the fair value option in IAS 28 is applied and the effects of that diversity on the classification of income and expenses in the statement of profit or loss in accordance with IFRS 18 Presentation and Disclosure in Financial Statements. They said clarity on this matter is particularly important because more entities are considering whether to elect that option as part of their implementation of IFRS 18.

The IASB’s proposed narrow-scope amendments aim to improve consistency in application and provide timely clarity ahead of the effective date of IFRS 18.

The IASB has set a shorter comment period to allow for any amendments to be completed in time for the implementation of IFRS 18.

The Exposure Draft will be open for comment for 60 days, with the comment period closing on 20 April 2026. The IASB plans to issue any resulting amendments by mid-2026.

How to respond to the Exposure Draft

Stakeholders can respond to the request for comment on the Exposure Draft by submitting a comment letter below.

Find out more about how to submit the most effective response to our consultation.

Note: Please ensure you upload your comment letter as an editable PDF (at least one file must be uploaded). We do not accept Word documents, which will fail to upload. Please also ensure there are no periods or other reserved characters in the file name because these will cause an error.

All comment letters will be on the public record and posted on our website unless the respondent requests confidentiality. Such requests will not normally be granted without a good reason—for example, commercial confidence. If you would like to request confidentiality, please contact us before submitting your letter.